94 related articles for article (PubMed ID: 31406042)
21. Perfusion culture maintained with an air-liquid interface to stimulate epithelial cell organization in renal organoids in vitro.
Sekiya S; Kikuchi T; Shimizu T
BMC Biomed Eng; 2019; 1():15. PubMed ID: 32903332
[TBL] [Abstract][Full Text] [Related]
22. A new approach for realizing the "antioncogram".
Köpf-Maier P
Life Sci; 1992; 50(22):1711-8. PubMed ID: 1588802
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
24. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
25. Tumor Organoids Fill the Niche.
Shroyer NF
Cell Stem Cell; 2016 Jun; 18(6):686-687. PubMed ID: 27257754
[TBL] [Abstract][Full Text] [Related]
26. Designer matrices for intestinal stem cell and organoid culture.
Gjorevski N; Sachs N; Manfrin A; Giger S; Bragina ME; Ordóñez-Morán P; Clevers H; Lutolf MP
Nature; 2016 Nov; 539(7630):560-564. PubMed ID: 27851739
[TBL] [Abstract][Full Text] [Related]
27. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
28. Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer.
Elbadawy M; Usui T; Yamawaki H; Sasaki K
Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29843359
[TBL] [Abstract][Full Text] [Related]
29. An organoid culture assay (OCA) for determining the drug sensitivity of human tumors.
Köpf-Maier P; Kolon B
Int J Cancer; 1992 Apr; 51(1):99-107. PubMed ID: 1563848
[TBL] [Abstract][Full Text] [Related]
30. Challenges in Bio-fabrication of Organoid Cultures.
Peng W; Datta P; Wu Y; Dey M; Ayan B; Dababneh A; Ozbolat IT
Adv Exp Med Biol; 2018; 1107():53-71. PubMed ID: 29855825
[TBL] [Abstract][Full Text] [Related]
31. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
Burkhart RA; Baker LA; Tiriac H
Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
[TBL] [Abstract][Full Text] [Related]
32. Organoids in cancer research.
Drost J; Clevers H
Nat Rev Cancer; 2018 Jul; 18(7):407-418. PubMed ID: 29692415
[TBL] [Abstract][Full Text] [Related]
33. What role could organoids play in the personalization of cancer treatment?
Francies HE; Garnett MJ
Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
[TBL] [Abstract][Full Text] [Related]
34. [Establishment and application of gastric and gastric cancer organoids].
Fan S; Yin J; Wang M; Guan W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1315-1320. PubMed ID: 30506544
[TBL] [Abstract][Full Text] [Related]
35. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids.
A P; Xu X; Wang C; Ye L; Yang J
Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662
[TBL] [Abstract][Full Text] [Related]
36. Drug response in organoids generated from frozen primary tumor tissues.
Walsh AJ; Cook RS; Sanders ME; Arteaga CL; Skala MC
Sci Rep; 2016 Jan; 6():18889. PubMed ID: 26738962
[TBL] [Abstract][Full Text] [Related]
37. Organoid cultures for the analysis of cancer phenotypes.
Sachs N; Clevers H
Curr Opin Genet Dev; 2014 Feb; 24():68-73. PubMed ID: 24657539
[TBL] [Abstract][Full Text] [Related]
38. Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P; Canet-Jourdan C; Annereau M; Zajac O; Gelli M; Broutin S; Mercier L; Paci A; Lemare F; Ducreux M; Elias D; Malka D; Boige V; Goéré D; Jaulin F
Int J Pharm; 2017 Oct; 531(1):143-152. PubMed ID: 28803938
[TBL] [Abstract][Full Text] [Related]
39. Patient-derived tumor organoids for prediction of cancer treatment response.
Nagle PW; Plukker JTM; Muijs CT; van Luijk P; Coppes RP
Semin Cancer Biol; 2018 Dec; 53():258-264. PubMed ID: 29966678
[TBL] [Abstract][Full Text] [Related]
40. An optimal serum-free defined condition for in vitro culture of kidney organoids.
Nishikawa M; Kimura H; Yanagawa N; Hamon M; Hauser P; Zhao L; Jo OD; Yanagawa N
Biochem Biophys Res Commun; 2018 Jul; 501(4):996-1002. PubMed ID: 29777692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
